Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.29 is 156% above its 2-year average of -2.30, near the high end of its 2-year range (-5.36–1.29).
146.82% above its 12-month average of -2.76.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.55.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 4 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-05T10:50:31.056Z. Historical observations retain their original dates. Historical series through 2026-10-02.
EARNINGS PER SHARE (EPS)
1.29
EARNINGS PER SHARE (EPS) AVG TTM
-2.76
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+146.82%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Hinge Health, Inc.
Market Cap
$7.56B
Earnings Per Share (EPS)
1.29
TTM Avg
-2.76
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.02B
Earnings Per Share (EPS)
1.40
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$6.63B
Earnings Per Share (EPS)
19.92
TTM Avg
19.26
3Y Avg
18.34
5Y Avg
18.42
Market Cap
$6.47B
Earnings Per Share (EPS)
-0.63
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$5.61B
Earnings Per Share (EPS)
-3.31
TTM Avg
-2.88
3Y Avg
-2.49
5Y Avg
-2.72
Market Cap
$9.67B
Earnings Per Share (EPS)
3.43
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$5.35B
Earnings Per Share (EPS)
-4.76
TTM Avg
-5.40
3Y Avg
-5.28
5Y Avg
-3.57
Market Cap
$5.22B
Earnings Per Share (EPS)
0.85
TTM Avg
1.12
3Y Avg
0.90
5Y Avg
0.76
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hinge Health, Inc. (HNGE) | $7.56B | 1.29 | -2.76 | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 1.40 | -0.79 | -1.41 | -1.76 |
| Chemed Corporation (CHE)vs › | $6.63B | 19.92 | 19.26 | 18.34 | 18.42 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | -0.63 | 0.57 | 0.18 | -0.06 |
| Insulet Corp. (PODD)vs › | $9.12B | 5.35 | 4.74 | 3.13 | 2.14 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | -3.31 | -2.88 | -2.49 | -2.72 |
| Henry Schein, Inc. (HSIC)vs › | $9.67B | 3.43 | 3.18 | 3.37 | 3.47 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.35B | -4.76 | -5.40 | -5.28 | -3.57 |
| Doximity, Inc. (DOCS)vs › | $5.22B | 0.85 | 1.12 | 0.90 | 0.76 |
| Molina Healthcare, Inc. (MOH)vs › | $9.89B | 0.19 | 14.72 | 15.46 | 14.11 |
Trailing EPS (TTM)
$1.29
Forward EPS (Est.)
$2.32
P/E Ratio
75.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -5.36 |
| 2024-12-31 | -0.15 |
| 2023-12-31 | -1.39 |
